Skip to main content
IMRX logo

IMRX · Immuneering Corp · Holdings

Track IMRX — free
$3.42 -0.08 (-2.28%) Play latest call Q3 2025 earnings call transcript
Market Cap
$220.84M
Shares
64.76M
Volume · Nov 19 190.7K Avg daily vol (3M) 730.02K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 132
Total Value: $143,434,330
Total Shares: 35,026,720
Showing 1–100 of 137 holdings by value · page 1 of 2

Institutional Ownership Trend

21 quarters

Holder Concentration

Share of 13F common-share value, across 132 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
26.2%
Dec 2023 → Sep 2026 · range 19.6% – 33.7%
−1.9 pts
Top 5
58.3%
Dec 2023 → Sep 2026 · range 57.4% – 79.5%
−2.7 pts
Top 10
72.3%
Dec 2023 → Sep 2026 · range 72.3% – 92.1%
−1.7 pts
HHI
1,066
Dec 2023 → Sep 2026 · range 872 – 1,534
Broadly held−84

Who Holds IMRX

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 131 filers, like-for-like change +1.7%; actively managed books -8.1%; index-like books +23.0%.

Holder type Share Filers Change
Registered adviser 25.6% 61 -17.0%
Exempt adviser 2.1% 1 +0.3%
Adviser 0.7% 4 +12.6%
Bank 6.5% 11 -0.3%
Broker-dealer 0.3% 3 +161.6%
Benefit plan 0.0% 2 +1697.0%
Non-US 0.2% 3 -35.6%
Holding company 45.2% 7 +10.0%
Unknown 19.3% 39 +15.8%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

131 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
1
0.763% of filers hold it in their top 10
Jun 30, 2026: 2
Holders above 5%
0
median weight 0.000%
Jun 30, 2026: 0
Crowding
—
the issuer has more than one class of common stock, so its count is the total across classes
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
the issuer has more than one class of common stock, so its count is the total across classes
Top 10 holders
72.3%
of 13F shares, Herfindahl 0.107
Active holders
-8.1%
like-for-like share change of active filers
5% stakes on record
5
0 13D, 5 13G (2 institutional, 2 passive, 1 exempt)
How long holders have held it value-weighted 6.9 quarters
Under 1 year 23.2% 1 to 3 years 66.6% 3 years or more 10.2% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $901,679 (4 buying, 3 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$5.28
estimated per share
Jun 30, 2026: $5.34
Quarter-end price
$4.09
implied by 13F values
Estimated gain or loss
-22.5%
price against the estimated cost
Estimated at a loss
99.0%
of costed 13F value

Estimated cost covers 91.2% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies IMRX's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 KURA Kura Oncology, Inc. 3
2 ALNY Alnylam Pharmaceuticals, Inc. 3
3 BA Boeing Co 5
4 GEV GE Vernova Inc. 6
5 GE General Electric Co 6
6 IBM International Business Machines Corp 6
7 NVDA Nvidia Corp 8
8 AVGO Broadcom Inc. 7
9 AAPL Apple Inc. 8
10 AMZN Amazon Com Inc 8

Shareholder Targets

13F filers that own its peers but not IMRX, quarter ended Sep 30, 2026

Found through its holder-overlap peers: KURA, ALNY, BA, GEV, GE, IBM, NVDA, AVGO, AAPL, AMZN, GOOGL, MU, AMD, COF, MMM, INTC, LLY, MSFT, CRWD, VLO. 7,098 filers in all.

# Filer In peers
1 Capital Research Global Investors Adviser, Diversified active $269,153,650,143 14 held
2 Capital World Investors Adviser, Diversified active $239,617,530,420 17 held
3 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $157,353,675,386 19 held
4 Capital International Investors Adviser, Diversified active $155,070,335,686 13 held
5 Amundi Holding company, Index-like $152,119,437,207 19 held
6 FRANKLIN RESOURCES INC Adviser, Diversified active $131,969,906,455 20 held
7 Berkshire Hathaway Inc Insurer, Concentrated $112,497,870,320 3 held
8 DIMENSIONAL FUND ADVISORS LP Registered adviser, Diversified active $105,514,343,396 20 held
9 LILLY ENDOWMENT INC Unknown, Unknown $104,214,698,904 1 held
10 PNC FINANCIAL SERVICES GROUP, INC. Bank, Concentrated $83,260,888,689 20 held

Fund Ownership of IMRX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 8.73% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.52% 983,673
Index ETFs 7.21% 4,671,057
Active ETFs 0.01% 3,663
Active funds 11.26% 7,289,887
Unclassified 0.08% 52,296
All registered funds 20.07% 13,000,576
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
29
Increased
49
Decreased
28
Sold Out
9
Unchanged
26

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +20
Institutional value: -16.6%
Shares held: +1.7%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 137
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 137 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1790340 CUSIP 45254E107 13F (30d) 134 filings 122 filers Visit website Investor relations